Brief: Pure Biologics Completes Project On Antibodies Selection Platform PureSelect2
Oct 29 (Reuters) - Pure Biologics SA PUR1.WA :
* COMPLETES REALISATION OF LAST STAGE OF PROJECT INCLUDING
DEVELOPMENT WORKS
* PROJECT ON DEMONSTRATION OF EFFECTIVENESS OF PLATFORM FOR
SELECTION OF ANTIBODIES VIA IN VITRO METHOD PURESELECT2
* ASSESSES DEGREE OF IMPLEMENTATION OF ALL PROJECT
MILESTONES AT
100%, ENTIRE PROJECT COMPLETE
Source text for Eikon: ID:nEM3DbnJHa
Further company coverage: PUR1.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Multiqure SA
See all newsBrief: Selvita To Expand Its Operations Through New Biological Drug Business
Brief: Pure Biologics FY Net Loss Widens To 25.6 Mln Zlotys
Brief: Pure Biologics Signs Term Sheet With ACRX Investments On Potential Financing
Brief: Pure Biologics Signs Deal For Subsidy With Poland's Medical Research Agency
Brief: Pure Biologics To Seek Extra Financing For PB003 And PB004 Projects